The lack of effect of ziprasidone on platelet serotonin concentration in schizophrenic patients

Psychopharmacology (Berl). 2012 Feb;219(4):1179-81. doi: 10.1007/s00213-011-2528-5. Epub 2011 Oct 12.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / pharmacology*
  • Antipsychotic Agents / therapeutic use
  • Blood Platelets / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Male
  • Piperazines / administration & dosage
  • Piperazines / pharmacology*
  • Piperazines / therapeutic use
  • Psychotic Disorders / drug therapy
  • Schizophrenia / drug therapy*
  • Serotonin / metabolism*
  • Serotonin Antagonists / administration & dosage
  • Serotonin Antagonists / pharmacology
  • Serotonin Antagonists / therapeutic use
  • Thiazoles / administration & dosage
  • Thiazoles / pharmacology*
  • Thiazoles / therapeutic use
  • Time Factors

Substances

  • Antipsychotic Agents
  • Piperazines
  • Serotonin Antagonists
  • Thiazoles
  • Serotonin
  • ziprasidone